Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer
Status unconfirmed · Not applicable
Conditions studied: Breast Cancer
In brief
This pilot study is an investigation of feasibility of moderate dose omega-3 fatty acid supplementation in pre-menopausal women at high risk for breast cancer who are considering future pregnancy. The goal of this pilot study is to determine feasibility of the study, document compliance with omega-3 fatty acid supplementation in this population and identify novel biomarkers modulated by moderate dose omega-3 fatty acids in this population.
Key facts
- Study ID
- NCT03383835
- Run by
- Lauren Nye
- People needed
- 11
- Starts
- 2018-02-05
- Expected to finish
- 2024-03-01
- Last updated by the study team
- 2023-05-23
Who can join
Age: 21 and older, up to 40. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women age 21 - 40 must be pre-menopausal as defined as having intact ovaries with regular menses or if not menstruating, have a premenopausal status confirmed by serum follicle-stimulating hormone (FSH) and estradiol.
- Women must be considered at high risk for breast cancer based on family history (first or second degree relative diagnosed with breast cancer under the age of 60), prior precancerous biopsy or a 5-year Gail model risk estimate of ≥ 1.7% or 10 year Tyrer-Cuzick risk of 2x population risk as listed in the model.
- Women must indicate that they are still considering future pregnancy and childbearing.
- Women must be one year from pregnancy and breast-feeding.
- Women must be willing to take supplemental omega-3 fatty acids provided by the study.
You may not qualify if…
- Women actively undergoing in-vitro fertilization or fertility treatments are excluded.
- Women currently pregnant or breast-feeding at time of study consent.
- Women with an active malignancy.
- Women on anticoagulation.
- Women with bilateral breast implants or tram flap reconstruction.
- Women who have had radiation to both breasts.
- Women with current mammographic or clinical breast exam mass which is suspicious for breast cancer and malignancy has not been ruled out.
Where it is running
- The University of Kansas Cancer Center — Westwood, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.